These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32508764)

  • 1. Anti-HFRS Human IgG Produced in Transchromosomic Bovines Has Potent Hantavirus Neutralizing Activity and Is Protective in Animal Models.
    Perley CC; Brocato RL; Wu H; Bausch C; Karmali PP; Vega JB; Cohen MV; Somerville B; Kwilas SA; Principe LM; Shamblin J; Chivukula P; Sullivan E; Hooper JW
    Front Microbiol; 2020; 11():832. PubMed ID: 32508764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
    Hooper JW; Moon JE; Paolino KM; Newcomer R; McLain DE; Josleyn M; Hannaman D; Schmaljohn C
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():110-7. PubMed ID: 24447183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
    Hooper JW; Josleyn M; Ballantyne J; Brocato R
    Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.
    Hooper JW; Custer DM; Thompson E; Schmaljohn CS
    J Virol; 2001 Sep; 75(18):8469-77. PubMed ID: 11507192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three asymptomatic animal infection models of hemorrhagic fever with renal syndrome caused by hantaviruses.
    Perley CC; Brocato RL; Kwilas SA; Daye S; Moreau A; Nichols DK; Wetzel KS; Shamblin J; Hooper JW
    PLoS One; 2019; 14(5):e0216700. PubMed ID: 31075144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of human ACE2 transgenic Syrian hamsters from SARS CoV-2 variants by human polyclonal IgG from hyper-immunized transchromosomic bovines.
    Gilliland T; Liu Y; Li R; Dunn M; Cottle E; Terada Y; Ryckman Z; Alcorn M; Vasilatos S; Lundy J; Larson D; Wu H; Luke T; Bausch C; Egland K; Sullivan E; Wang Z; Klimstra WB
    bioRxiv; 2021 Jul; ():. PubMed ID: 34341790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: potential application for immunotherapy and passive immunization.
    Xu Z; Wei L; Wang L; Wang H; Jiang S
    Biochem Biophys Res Commun; 2002 Nov; 298(4):552-8. PubMed ID: 12408987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome.
    Hooper JW; Brocato RL; Kwilas SA; Hammerbeck CD; Josleyn MD; Royals M; Ballantyne J; Wu H; Jiao JA; Matsushita H; Sullivan EJ
    Sci Transl Med; 2014 Nov; 6(264):264ra162. PubMed ID: 25429055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.
    Boudreau EF; Josleyn M; Ullman D; Fisher D; Dalrymple L; Sellers-Myers K; Loudon P; Rusnak J; Rivard R; Schmaljohn C; Hooper JW
    Vaccine; 2012 Mar; 30(11):1951-8. PubMed ID: 22248821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.
    Luke T; Wu H; Zhao J; Channappanavar R; Coleman CM; Jiao JA; Matsushita H; Liu Y; Postnikova EN; Ork BL; Glenn G; Flyer D; Defang G; Raviprakash K; Kochel T; Wang J; Nie W; Smith G; Hensley LE; Olinger GG; Kuhn JH; Holbrook MR; Johnson RF; Perlman S; Sullivan E; Frieman MB
    Sci Transl Med; 2016 Feb; 8(326):326ra21. PubMed ID: 26888429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of CD40 ligand or granulocyte-macrophage colony stimulating factor into Hantaan virus (HTNV) virus-like particles significantly enhances the long-term immunity potency against HTNV infection.
    Dong Y; Ma T; Zhang X; Ying Q; Han M; Zhang M; Yang R; Li Y; Wang F; Liu R; Wu X
    J Med Microbiol; 2019 Mar; 68(3):480-492. PubMed ID: 30657443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure.
    Haese N; Brocato RL; Henderson T; Nilles ML; Kwilas SA; Josleyn MD; Hammerbeck CD; Schiltz J; Royals M; Ballantyne J; Hooper JW; Bradley DS
    PLoS Negl Trop Dis; 2015; 9(6):e0003803. PubMed ID: 26046641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.
    Golden JW; Maes P; Kwilas SA; Ballantyne J; Hooper JW
    J Virol; 2016 Jan; 90(7):3515-29. PubMed ID: 26792737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China.
    Li Z; Zeng H; Wang Y; Zhang Y; Cheng L; Zhang F; Lei Y; Jin B; Ma Y; Chen L
    Hum Vaccin Immunother; 2017 Apr; 13(4):802-807. PubMed ID: 27824286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase 2a Randomized, Double-Blind, Dose-Optimizing Study to Evaluate the Immunogenicity and Safety of a Bivalent DNA Vaccine for Hemorrhagic Fever with Renal Syndrome Delivered by Intramuscular Electroporation.
    Hooper J; Paolino KM; Mills K; Kwilas S; Josleyn M; Cohen M; Somerville B; Wisniewski M; Norris S; Hill B; Sanchez-Lockhart M; Hannaman D; Schmaljohn CS
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32664486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of anti-hantavirus antibodies in forest workers in the north-east of Poland].
    Grygorczuk S; Pancewicz S; Zajkowska J; Kondrusik M; Swierzbińska R; Moniuszko A; Pawlak-Zalewska W
    Przegl Epidemiol; 2008; 62(3):531-7. PubMed ID: 19108515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle.
    Dye JM; Wu H; Hooper JW; Khurana S; Kuehne AI; Coyle EM; Ortiz RA; Fuentes S; Herbert AS; Golding H; Bakken RA; Brannan JM; Kwilas SA; Sullivan EJ; Luke TC; Smith G; Glenn G; Li W; Ye L; Yang C; Compans RW; Tripp RA; Jiao JA
    Sci Rep; 2016 Apr; 6():24897. PubMed ID: 27109916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain.
    Liang M; Mahler M; Koch J; Ji Y; Li D; Schmaljohn C; Bautz EK
    J Med Virol; 2003 Jan; 69(1):99-107. PubMed ID: 12436484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a multi-epitope DNA vaccine against hantavirus.
    Zhao C; Sun Y; Zhao Y; Wang S; Yu T; Du F; Yang XF; Luo E
    Hum Vaccin Immunother; 2012 Feb; 8(2):208-15. PubMed ID: 22426376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and evaluation of DNA vaccine encoding Hantavirus glycoprotein N-terminal fused with lysosome-associated membrane protein.
    Jiang DB; Sun YJ; Cheng LF; Zhang GF; Dong C; Jin BQ; Song CJ; Ma Y; Zhang FL; Yang K
    Vaccine; 2015 Jun; 33(29):3367-76. PubMed ID: 26027907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.